Pilot and feasibility clinical research grants in diabetes, endocrine and metabolic diseases

The National Institute of Diabetes and Digestive and Kidney Diseases invites applications for Aids-related pilot and feasibility clinical research grants in diabetes, and endocrine and metabolic diseases. This Aids-related R21 funding opportunity announcement encourage pilot and feasibility clinical research related to the prevention or treatment of diabetes and endocrine and genetic metabolic diseases. 

Direct costs are limited to US$275,000 over the two years of the R21 award, with no more than US$200,000 in direct costs allowed in any single year. 

Deadline: 7 May 2015

More information is available on the NIH website